Inozyme Pharma Stock Price on July 17, 2024
| INZY Stock | USD 2.98 0.26 9.56% |
Below is the normalized historical share price chart for Inozyme Pharma extending back to July 24, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Inozyme Pharma stands at 2.98, as last reported on the 11th of December 2024, with the highest price reaching 2.98 and the lowest price hitting 2.72 during the day.
If you're considering investing in Inozyme Stock, it is important to understand the factors that can impact its price. Inozyme Pharma holds Efficiency (Sharpe) Ratio of -0.23, which attests that the entity had a -0.23% return per unit of risk over the last 3 months. Inozyme Pharma exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Inozyme Pharma's Market Risk Adjusted Performance of (0.58), risk adjusted performance of (0.12), and Standard Deviation of 4.03 to validate the risk estimate we provide.
At this time, Inozyme Pharma's Other Stockholder Equity is fairly stable compared to the past year. Capital Stock is likely to rise to 6,300 in 2024, whereas Total Stockholder Equity is likely to drop slightly above 87.9 M in 2024. . At this time, Inozyme Pharma's Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 0.16 in 2024, whereas Price Earnings Ratio is likely to drop (3.26) in 2024. Inozyme Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 24th of July 2020 | 200 Day MA 4.9334 | 50 Day MA 4.0935 | Beta 1.54 |
Inozyme |
Sharpe Ratio = -0.2322
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | INZY |
Estimated Market Risk
| 3.92 actual daily | 34 66% of assets are more volatile |
Expected Return
| -0.91 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.23 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Inozyme Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Inozyme Pharma by adding Inozyme Pharma to a well-diversified portfolio.
Price Book 2.1106 | Book Value 1.29 | Enterprise Value 89.9 M | Enterprise Value Ebitda (4.25) | Shares Float 36.5 M |
Related Headline
Dianthus Therapeutics Headline on 17th of July 2024
Filed transaction by Dianthus Therapeutics Officer Chief Accounting Officer. Grant, award or other acquisition pursuant to Rule 16b-3
Inozyme Pharma Valuation on July 17, 2024
It is possible to determine the worth of Inozyme Pharma on a given historical date. On July 17, 2024 Inozyme was worth 5.67 at the beginning of the trading date compared to the closed value of 5.74. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Inozyme Pharma stock. Still, in general, we apply an absolute valuation method to find Inozyme Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Inozyme Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Inozyme Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 5.56 | 5.80 | 5.51 | 5.77 | 435,067 | |
07/17/2024 | 5.67 | 5.83 | 5.55 | 5.74 | 212,896 |
| 5.69 | 5.76 | 5.32 | 5.32 | 293,453 |
| Backtest Inozyme Pharma | | | Inozyme Pharma History | | | Inozyme Pharma Valuation | Previous | Next |
Inozyme Pharma Trading Date Momentum on July 17, 2024
| On July 18 2024 Inozyme Pharma was traded for 5.32 at the closing time. The top price for the day was 5.76 and the lowest listed price was 5.32 . The trading volume for the day was 293.5 K. The trading history from July 18, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 7.32% . The trading delta at closing time against the current closing price is 1.57% . |
Inozyme Pharma Fundamentals Correlations and Trends
By evaluating Inozyme Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Inozyme Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Inozyme financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Inozyme Pharma Stock history
Inozyme Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Inozyme is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Inozyme Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Inozyme Pharma stock prices may prove useful in developing a viable investing in Inozyme Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 51.8 M | 30.6 M | |
| Net Loss | -60.4 M | -63.4 M |
Inozyme Pharma Quarterly Net Working Capital |
|
Inozyme Pharma Stock Technical Analysis
Inozyme Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Inozyme Pharma Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Inozyme Pharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Inozyme Pharma December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Inozyme Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Inozyme Pharma shares will generate the highest return on investment. By undertsting and applying Inozyme Pharma stock market strength indicators, traders can identify Inozyme Pharma entry and exit signals to maximize returns
Inozyme Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Inozyme Pharma's price direction in advance. Along with the technical and fundamental analysis of Inozyme Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Inozyme to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (0.89) | |||
| Total Risk Alpha | (1.39) | |||
| Treynor Ratio | (0.59) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Inozyme Stock Analysis
When running Inozyme Pharma's price analysis, check to measure Inozyme Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inozyme Pharma is operating at the current time. Most of Inozyme Pharma's value examination focuses on studying past and present price action to predict the probability of Inozyme Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inozyme Pharma's price. Additionally, you may evaluate how the addition of Inozyme Pharma to your portfolios can decrease your overall portfolio volatility.